Precision prostate care that preserves what matters most to men
Incision-free, radiation-free, and versatile prostate tissue ablation with no hospital stay
Precise prostate tissue ablation with a low risk of serious side effects
The TULSA Procedure is performed inside an MRI scanner, allowing your doctor to see the prostate and surrounding structures in real time. This helps them plan and adjust the treatment based on your unique prostate size, shape, and location of disease.
Using this guidance, directional ultrasound energy is delivered through the urethra to precisely target prostate tissue while helping protect nearby nerves and healthy structures. Real-time monitoring allows the physician to ablate only what’s needed, which may help reduce the risk of serious side effects such as urinary incontinence and erectile dysfunction. The procedure is completed in a single session—with no incisions, no radiation and no hospital stay.
Dealing with the most common prostate diseases
As they age, many men are affected by one of three prostate issues. Click on one of the options below to learn more.
Prostate Cancer
A common, usually slow growing cancer that begins within the prostate, but can spread.
BPH
Also known as an enlarged prostate, BPH (Benign Prostatic Hyperplasia) is an overgrowth of tissue that restricts urine flow.
Radio-Recurrent Prostate Cancer
In some cases, radiation therapy fails to eliminate cancer completely, requiring more treatment.
Landmark CAPTAIN clinical trial
Traditionally, many men with prostate cancer have been treated with radical prostatectomy, a surgery that removes the entire prostate gland.
Results from the landmark CAPTAIN randomized control trial has shown that men treated with the TULSA Procedure experience better preservation of urinary continence and erectile function, less pain after the procedure, faster recovery, fewer hospitalizations for complications, and a quicker return to normal activities and work compared with traditional prostate surgery.1
Once I understood the difference, the TULSA Procedure was an easy decision. It not only treated my cancer effectively, it also protected the quality-of-life things that are important to me. I feel incredibly blessed and want to make sure other men know about this option.
Leonard Wheeler, TULSA Procedure Patient
I opted for TULSA because I wanted to stay away from any adverse side effects. I didn’t have to stay overnight at a hospital. There is an alternative besides radiation and surgery. It’s an amazing procedure.
Don, TULSA Procedure Patient
If more people knew about TULSA-PRO and its amazing results it would change the game. The therapies that were presented to me seem antiquated now that I’ve been through this and learned more about TULSA-PRO. I feel like a new man.
Robert, TULSA Procedure Patient
Have questions? We’re here to help.
If you have questions about the TULSA Procedure, connect with one of our helpful Patient Educators.
Important Safety Information
All surgical treatments carry risks, and individual outcomes may vary based on patient and disease characteristics. The most common side effects of the TULSA Procedure are mild and temporary, such as urinary symptoms, blood in the urine, minor infections, discomfort in the pelvic, genital, abdominal or anorectal area.
More serious risks, though rare, can include anesthesia risk, sexual dysfunction, urine leakage, urethral discharge, urinary tract infection, deep vein thrombosis, rectal injury, and tightening of the bladder outlet and/or urethra, which may require additional intervention. Patients may also experience worsening urinary symptoms, such as increased frequency, urgency, or the need to urinate at night.
No claim is made that TULSA Procedure will cure any medical condition or eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required. Not all patients will experience the same results.
Rx only. TULSA-PRO is indicated for ultrasound ablation of prostate tissue.
References
- Klotz, et al. “Randomized control trial evaluating MRI-guided transurethral ultrasound ablation (TULSA) versus radical prostatectomy.” European Association of Urology 2026 Congress.
- Olivares, et al. “Perioperative outcomes from a randomized controlled trial comparing MRI-guided transurethral ultrasound ablation (TULSA) to robot-assisted radical prostatectomy (RARP).” The Journal of Clinical Oncology (2026).
- Eggener, et al. “Pivotal study of MRI-guided transurethral ultrasound ablation (TULSA) of localized prostate cancer: 5-year follow up.” Urologic Oncology (2024).
- Viitala et al, “Magnetic resonance imaging-guided transurethral ultrasound ablation for benign prostatic obstruction: 1-year clinical outcomes of a phase II study.” BJU Int (2025).